In Part 1 of our series, Hiring Women Execs in Biotech, VC Firms is a Moneyball Play, we shared a range of statistics showing that companies with women in senior executive and board positions achieved superior financial returns. In Part 2, we’re going to look at why more biotech companies and VC firms aren’t making the Moneyball play, and what some...Read More
Leora Schiff: Kyle Serikawa and I were recently talking about the missed opportunities for biotech companies and lifescience VC firms who fail to include women among their senior leadership. Kyle’s the baseball expert, so I’m going to hand off to him to explain about Moneyball. Kyle Serikawa: The concept of Moneyball, as practiced by the Oakland A’s in the early...Read More
Timmerman Report Gives You Consistent In-Depth Reporting on Biotechnology. Get Your Edge.